Clopidogrel (Plavix®) and cardiac surgical patients: Implications for platelet function monitoring and postoperative bleeding

Platelets

Volumn 15, Issue 5, 2004, Pages 325-332

  Tanaka, Kenichi A ^a,b   Szlam, Fania ^a   Kelly, Andrew B ^a   Vega, J David ^a   Levy, Jerrold H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' 4 FLUOROSULFONYLBENZOYLADENOSINE; ACETYLSALICYLIC ACID; ADENOSINE DERIVATIVE; ADENOSINE DIPHOSPHATE; APROTININ; CLOPIDOGREL; ENOXAPARIN; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; HEPARIN; UNCLASSIFIED DRUG; 5' (4 FLUOROSULFONYLBENZOYL)ADENOSINE; 5'-(4-FLUOROSULFONYLBENZOYL)ADENOSINE; ADENOSINE; DRUG DERIVATIVE; PURINE P2 RECEPTOR; TICLOPIDINE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DEMOGRAPHY; FEMALE; HEMATOLOGICAL PROCEDURES; HUMAN; HUMAN CELL; IN VITRO STUDY; ISCHEMIC HEART DISEASE; LABORATORY TEST; MALE; PATIENT MONITORING; PLATELET AGGREGOMETRY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; TUBE; BLOOD; BLOOD CLOTTING PARAMETERS; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; RETROSPECTIVE STUDY; THROMBOCYTE; TIME;

ADENOSINE; ADENOSINE DIPHOSPHATE; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; POSTOPERATIVE HEMORRHAGE; RECEPTORS, PURINERGIC P2; RETROSPECTIVE STUDIES; THROMBELASTOGRAPHY; TICLOPIDINE; TIME FACTORS;

EID: 3843139502     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100410001710236     Document Type: Article

References (23)

1. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
2. Mehta S R, Yusuf S. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J 2000; 21: 2033-41.
3. Hongo R H, Ley J, Dick S E, Yee R R. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 2002; 40: 231-7.
4. Yende S, Wunderink R G. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001; 29: 2271-5.
5. Tuman K J, Spiess B D, McCarthy R J, Ivankovich A D. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Anesth Analg 1989; 69: 69-75.
6. Shore-Lesserson L, Manspeizer H E, DePerio M, Francis S, Vela-Cantos F, Ergin M A. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analesia 1999; 88: 312-9.
7. Khurana S, Mattson J C, Westley S, O'Neill W W, Timmis G C, Safian R D. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 1997; 130: 401-11.
8. Storey R F, May J A, Wilcox R G, Heptinstall S. A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies. Thromb Haemost 1999; 82: 1307-11.
9. Lau W C, Waskell L A, Watkins P B, Neer C J, Horowitz K, Hopp A S, Tait A R, Carville D G, Guyer K E, Bates E R. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Circulation 2003; 107: 32-7.
10. Thiagarajan P, Tait J F. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem 1991; 266: 24302-7.
11. Harker L A, Marzec U M, Kelly A B, Chronos N R, Sundell I B, Hanson S R, Herbert J M. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation 1998; 98: 2461-9.
12. Jarvis G E, Humphries R G, Robertson M J, Leff P. ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors. Br J Pharmacol 2000; 129: 275-82.
13. Storey R F, Sanderson H M, White A E, May J A, Cameron K E, Heptinstall S. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol 2000; 110: 925-34.
14. Kikura M, Kazama T, Ikeda T, Sato S. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood. Platelets 2000; 11: 446-58.
15. Foster C J, Prosser D M, Agans J M, Zhai Y, Smith M D, Lachowicz J E, Zhang F L, Gustafson E, Monsma F J, Jr., Wiekowski M T, Abbondanzo S J, Cook D N, Bayne M L, Lira S A, Chintala M S. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 2001; 107: 1591-8.
16. Covic L, Singh C, Smith H, Kuliopulos A. Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak syndrome. Thromb Haemost 2002; 87: 722-7.
17. Barragan P, Bouvier J L, Roquebert P O, Macaluso G, Commeau P, Comet B, Lafont A, Camoin L, Walter U, Eigenthaler M. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation. Cathet Cardiovasc Int 2003; 59: 295-302.
18. Clark S C, Vitale N, Zacharias J, Forty J. Effect of low molecular weight heparin (fragmin) on bleeding after cardiac surgery. Ann Thorac Surg 2000; 69: 762-4; discussion 764-5.
19. Genoni M, Zeller D, Bertel O, Maloigne M, Turina M. Tirofiban therapy does not increase the risk of hemorrhage after emergency coronary surgery. J Thorac Cardiovasc Surg 2001; 122: 630-2.
20. Puskas J D, Williams W H, Duke P G, Staples J R, Glas K E, Marshall J J, Leimbach M, Huber P, Garas S, Sammons B H, McCall S A, Petersen R J, Bailey D E, Chu H, Mahoney E M, Weintraub W S, Guyton R A, Lytle B W, Bonchek L I. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: A prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125: 797-808.
21. Nader N D, Khadra W Z, Reich N T, Bacon D R, Salerno T A, Panos A L. Blood product use in cardiac revascularization: comparison of on- and off-pump techniques. Ann Thorac Surg 1999; 68: 1640-3.
22. Tanaka K A, Vega J D, Kelly A B, Hanson S R, Levy J H. Off-pump coronary bypass surgery in eptifibatide-induced thrombocytopenia. J Thromb Haemost 2003; 1: 392-394.
23. David J L, Limet R. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients. Thromb Haemost 1999; 82: 1417-21.